Insulet expands Omnipod 5 pump to people with Type 2 diabetes
The FDA clearance marks the first automated insulin delivery system for people with Type 2 diabetes.
Insulet expands Omnipod 5 pump to people with Type 2 diabetes Read More »
The FDA clearance marks the first automated insulin delivery system for people with Type 2 diabetes.
Insulet expands Omnipod 5 pump to people with Type 2 diabetes Read More »
Known as Stelo, the device is intended for people who don’t take insulin and costs $89 per month.
Dexcom prices first over-the-counter glucose monitor Read More »
The World Health Organization has declared an mpox outbreak to be a public health emergency of international concern.
Roche to increase global laboratory capacity for mpox testing Read More »
The guidance describes changes companies can make to medical devices without filing a new 510(k) or premarket approval supplement.
FDA seeks feedback on predetermined change control plans Read More »
Facilities reported challenges hiring and retaining qualified infection prevention personnel, according to the analysis by the HHS’ Office of Inspector General.
Belgium-based biopharma UCB is selling its Chinese neurology and allergy business to Singapore asset management firm CBC Group and Abu Dhabi investment company Mubadala.
UCB Offloads Neurology, Allergy Portfolio in China for $680M Read More »
¿Te has preguntado alguna vez cuántos kWh consume una casa al mes? El gasto energético de un hogar depende de distintos factores, pero especialmente de los electrodomésticos que se usan en casa. Quédate para descubrir cuánta electricidad está …
El 22 de marzo se celebra el Día Mundial del Agua. En la actualidad. 748 millones de personas en todo el mundo continuan teniendo serios problemas para acceder al agua. Un motivo para recordar la importancia que el agua potable tiene para el ser humano. Es aquí donde las fosas sé …
The Switzerland layoffs are the latest in Bayer’s 2024 workforce reductions, which already include 1,500 people and nearly half of the executive leadership team.
MBX Biosciences follows Bicara Therapeutics and Zenas Biopharma, which also announced last week their respective plans to go public in a potential boost to the recent slump in the IPO market.
MBX Unveils Plans for Nasdaq Debut, Joins Two Other IPO Hopefuls Read More »